ASGE Annual Postgraduate Course: Leveraging New Advances to Improve Patient Outcomes (Live and Virtual)

Pdf Summary

The document discusses Endoscopic Bariatric Therapies, focusing on the current options, efficacy, and long-term outcomes compared to medical and surgical approaches. Various procedures and technologies are highlighted, including Intragastric balloons, Gastric remodeling, Sleeve gastrectomy, Gastric bypass, and Small bowel interventions. The text emphasizes the importance of these therapies in managing obesity and related comorbidities, offering a non-surgical option for those who are not candidates for surgery. It also discusses the impact of different procedures on total weight loss and their safety profiles.<br /><br />Additionally, the document explains the mechanisms behind obesity, emphasizing the role of small bowel in energy homeostasis and the importance of duodenal therapies in improving metabolic diseases. The use of GLP-1 receptor agonists to treat diabetes and obesity is also highlighted, with a focus on their effects on glycemic control and appetite suppression.<br /><br />The text underlines the growing trend of combining different therapies, such as GLP-1 RAs with Intragastric balloons or Endoscopic sleeve gastroplasty, to achieve synergistic effects in weight loss and metabolic improvements. The conclusion calls for the integration of these innovative therapies into comprehensive, multidisciplinary centers for optimal outcomes in the management of obesity and related conditions.

Asset Subtitle

Allison R. Schulman, MD, MPH, FASGE

Keywords

Endoscopic Bariatric Therapies

Intragastric balloons

Gastric remodeling

Sleeve gastrectomy

Gastric bypass

Small bowel interventions

Obesity management

Metabolic diseases

GLP-1 receptor agonists

Comprehensive treatment centers